Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant - a cross-sectional study.
作者信息
Fernandez-Nieto D, Ortega-Quijano D, Suarez-Valle A, Jimenez-Cauhe J, Jaen-Olasolo P, Fernandez-Guarino M
机构信息
Dermatology Department, Ramon y Cajal University Hospital, Instituto de Investigación Sanitaria del Hospital Ramón y Cajal (Irycis), Universidad de Alcalá de Henares, Madrid, Spain.
出版信息
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e183-e185. doi: 10.1111/jdv.17051. Epub 2020 Dec 21.
Abstract
摘要
相似文献
1
Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant - a cross-sectional study.
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e183-e185. doi: 10.1111/jdv.17051. Epub 2020 Dec 21.
2
Acute acral cutaneous manifestations during the COVID-19 pandemic: a single-centre experience.
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e692-e694. doi: 10.1111/jdv.16777. Epub 2020 Jul 20.
3
Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?
J Cutan Med Surg. 2020 Jul/Aug;24(4):416-417. doi: 10.1177/1203475420928375. Epub 2020 May 11.
4
SARS-CoV-2, skin lesions and the need of a multidisciplinary approach.
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e659-e662. doi: 10.1111/jdv.16745. Epub 2020 Jul 2.
5
Pneumonia in Hospitalized Children During SARS-CoV-2 Pandemic. Is it All COVID-19? Comparison Between COVID and Non-COVID Pneumonia.
Pediatr Infect Dis J. 2021 Mar 1;40(3):e111-e113. doi: 10.1097/INF.0000000000003008.
6
Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings.
Br J Dermatol. 2021 Jan;184(1):184-185. doi: 10.1111/bjd.19564. Epub 2020 Nov 2.
7
[Impact of the SARS-CoV-2 pandemic on the start of prescriptions].
J Healthc Qual Res. 2020 Nov-Dec;35(6):402-403. doi: 10.1016/j.jhqr.2020.09.001. Epub 2020 Sep 29.
8
COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
BMJ Open. 2022 Apr 21;12(4):e056637. doi: 10.1136/bmjopen-2021-056637.
9
Self-reported cutaneous manifestations in 1429 Brazilian COVID-19-infected patients.
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e172-e173. doi: 10.1111/jdv.17024. Epub 2020 Nov 24.
10
High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
BMC Infect Dis. 2020 Dec 2;20(1):917. doi: 10.1186/s12879-020-05662-8.
引用本文的文献
1
Value of the Lymphocyte Transformation Test for the Diagnosis of Drug-Induced Hypersensitivity Reactions in Hospitalized Patients with Severe COVID-19.
Int J Mol Sci. 2023 Jul 17;24(14):11543. doi: 10.3390/ijms241411543.
2
Dermatopathology of COVID-19 infection and vaccination.
Pathologie (Heidelb). 2022 Aug;43(Suppl 1):114-118. doi: 10.1007/s00292-022-01126-9. Epub 2022 Oct 5.
3
SARS-CoV-2 and Skin: New Insights and Perspectives.
Biomolecules. 2022 Aug 31;12(9):1212. doi: 10.3390/biom12091212.
4
Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.
Biologics. 2021 Apr 27;15:107-113. doi: 10.2147/BTT.S302164. eCollection 2021.
5
Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology.
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e539-e541. doi: 10.1111/jdv.17322. Epub 2021 May 12.
6
COVID-19 "second wave" and vaccines: the dermatologists' perspective.
Int J Dermatol. 2021 Jul;60(7):889-890. doi: 10.1111/ijd.15547. Epub 2021 Mar 25.
本文引用的文献
1
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
Nature. 2021 Jul;595(7869):707-712. doi: 10.1038/s41586-021-03677-y. Epub 2021 Jun 7.
2
Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity.
J Clin Med. 2020 Oct 12;9(10):3261. doi: 10.3390/jcm9103261.
3
Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital.
Int J Dermatol. 2020 Nov;59(11):1353-1357. doi: 10.1111/ijd.15180. Epub 2020 Sep 24.
4
Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in 53 countries or regions.
Transbound Emerg Dis. 2021 Mar;68(2):213-215. doi: 10.1111/tbed.13819. Epub 2020 Sep 17.
5
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
6
Comment on 'Cutaneous manifestations in COVID-19: a first perspective' by Recalcati S.
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e299-e300. doi: 10.1111/jdv.16519.
7
Cutaneous manifestations in COVID-19: a first perspective.
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387.
8
Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.
Clin Infect Dis. 2020 Jul 28;71(15):713-720. doi: 10.1093/cid/ciaa203.
9
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件